Adaptimmune Therapeutics plc (ADAP) tumbled -5.13% or -0.3 to $5.46. It is approximately 776858 shares traded, which is 137.32% compare to the average total volume 565708. The market cap of ADAP is $570.43 million. The year to date change is -24.14%. The 52 week price range is from $4.82 to $14.62. Price of ADAP have changed -3.52% during last week. It have changed -9.02% over last month, -48.43% over last 3 months, -53.55% over last 6 months and -27.40% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ADAP is 8.24. It is 50.92% above current price. The 200-day Moving Averages for ADAP is 10.41. It is 90.66% above current price. The 52-week High is 14.62. It is 167.77% from the current price. The 52-week Low is 4.82. It is -11.72% from current price.
There are some statistics of ADAP. It is has market cap $570.43 million. The share outstanding is 104.57 million. The average volume is 565708. The percent of top 15 Institution holding is 74.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ADAP is -34.45%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ADAP is -28.49%.